(Q39360474)

11 September 2017

DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer (English)

1 reference

11 September 2017

0 references

1 reference

Ying Chen

1

1 reference

11 September 2017

Muxing Kang

2

1 reference

11 September 2017

Wenjie Lu

3

1 reference

11 September 2017

Qingqu Guo

4

1 reference

11 September 2017

Bo Zhang

5

1 reference

11 September 2017

Qiuping Xie

6

1 reference

11 September 2017

Yulian Wu

7

1 reference

11 September 2017

19 April 2012

1 reference

Journal of Cancer Research and Clinical Oncology

11 September 2017

1 reference

11 September 2017

138

1 reference

11 September 2017

9

1 reference

11 September 2017

1463-1474

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-012-1205-3

11 September 2017

0 references

cites work

DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Radioresistance, chemoresistance, and apoptosis resistance. The past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Serum biomarker panels for the detection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Parkinson disease protein DJ-1 converts from a zymogen to a protease by carboxyl-terminal cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1 decreases Bax expression through repressing p53 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Pancreatic cancer spheres are more than just aggregates of stem marker-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

A compendium of potential biomarkers of pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Gemcitabine-based combination treatment of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Cancer stem cells in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

21 January 2018

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1, a novel regulator of the tumor suppressor PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Overexpression of synuclein-gamma in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Molecular mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1 regulation of mitochondrial function and autophagy through oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

alpha-Synuclein locus triplication causes Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Apoptosis and melanoma chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Molecular cloning of human and mouse DJ-1 genes and identification of Sp1-dependent activation of the human DJ-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Proteomic analysis identified DJ-1 as a cisplatin resistant marker in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

DJ-1 up-regulates glutathione synthesis during oxidative stress and inhibits A53T alpha-synuclein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Apoptosis and cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1205-3

Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer.

21 January 2018

1 reference

12 December 2020

Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation

1 reference

12 December 2020

CEACAM1, a novel serum biomarker for pancreatic cancer

1 reference

12 December 2020

Epidemiology of pancreatic cancer

1 reference

12 December 2020

Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer

1 reference

12 December 2020

Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha.

1 reference

12 December 2020

p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.

1 reference

12 December 2020

10.1007/S00432-012-1205-3

Identifiers

DOI

1 reference

11 September 2017

1 reference